Xinluo Technology

Wuhan Xinluo Technology Co., Ltd. is a medical big data and artificial intelligence technology company specializing in the cardiac field. It focuses on using artificial intelligence technology to build a specialized intelligent full-process management system and service platform for cardiovascular disease diagnosis and treatment in China. It has signed a technical cooperation agreement with the China Cardiovascular Health Alliance and the Cardiovascular Health Research Institute to achieve information sharing and in-depth cooperation. The company aims to help medical institutions and doctors better utilize medical data and build a sound, unified, and standardized intelligent diagnosis and treatment system for cardiovascular diseases. Currently, more than 400 tertiary hospitals nationwide have begun using the Xinluo system. Xinluo Technology has developed China's first AI-powered intelligent diagnosis and treatment expert system for cardiovascular diseases with independent intellectual property rights. With this as its core, it has launched two core solutions: an intelligent cardiovascular disease full-process management system and an intelligent cardiovascular specialty internet hospital platform. These include multiple intelligent business modules and service platforms such as remote ECG network, intelligent screening, AI diagnosis and treatment, cardiology operations management, intelligent follow-up, doctor-patient community, and doctor-doctor community, fully meeting the clinical business needs of cardiovascular internal medicine. They help medical institutions at all levels promote the implementation of the national hierarchical diagnosis and treatment policy. By optimizing the service processes of medical institutions, improving service efficiency, and improving the matching between supply and demand of medical services, limited medical resources can serve patients to the greatest extent, providing patients with higher quality, more convenient, and more affordable medical services. In the future, Xinluo Technology will continue to strive to explore the frontiers of medical artificial intelligence. Adhering to the corporate philosophy of "innovation, leadership, and mission," it will continuously improve its technological innovation capability and management level to provide first-class products and solutions for intelligent diagnosis and treatment of cardiovascular and cerebrovascular diseases, establish intelligent diagnosis and treatment standards for single diseases of cardiovascular and cerebrovascular diseases, solve industry pain points, improve patient satisfaction, and promote the ecological development of the industry. It aims to build a first-class brand in China's intelligent diagnosis and treatment of cardiovascular and cerebrovascular specialties, making Xinluo Technology the most respected and trusted enterprise in China's smart healthcare industry. Holding company: Chengdu Bit Rhythm Technology Co., Ltd. Chengdu Bit Rhythm Technology Co., Ltd. is the holding company of Wuhan Xinluo Technology Co., Ltd. Bit Rhythm focuses on ECG acquisition and analysis technology, and is a high-tech enterprise integrating medical device research and development, production, sales, and technical services. Bit Rhythm has deep accumulation in the field of ECG acquisition and analysis. Adhering to the product philosophy of "New health, start from the heart," with mastering core technology as the cornerstone and improving user experience as the guide, it is committed to applying leading technologies such as biosensing, human signal processing, and artificial intelligence to the field of ECG monitoring.